Position in BIOA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$13,753,313
+$3,349,863 QoQ
Shares Held
786,353
0.0% QoQ
Ownership
1.77%
of shares outstanding
% of Portfolio
3.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Sands Capital Alternatives, LLC holds $13,753,313 across 1 Drug Manufacturers - Specialty & Generic name. BIOA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIOA |
BioAge Labs, Inc.
This page
|
786,353 | $13,753,313 |
All Filings in BIOA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,753,313 | 786,353 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $10,403,450 | 786,353 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,623,755 | 786,353 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,247,637 | 786,353 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,956,687 | 786,353 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,552,983 | 786,353 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $22,596,142 | 1,086,353 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||